Chinese CDMO WuXi AppTec has once again entered the crosshairs of the United States government after being added to the... Read more
Tag: #Global Trends
Drug Administration of Vietnam fines Minh Dan Pharma 90 million VND over marketing authorization violations
The Drug Administration of Vietnam, operating under the Ministry of Health, has officially handed down an administrative sanction decree targeting... Read more
Ministry of Health mandates stricter internet advertising controls and intensified crackdowns on counterfeit food
The Vietnam Food Administration (VFA), operating under the Ministry of Health, has dispatched an official directive to provincial and municipal... Read more
Haleon to invest Rs 2,000 crore to establish first manufacturing facility in India and South Asia
UK-based consumer healthcare giant Haleon, formerly known as GSK Consumer Healthcare, has announced an investment of approximately Rs 2,000 crore... Read more
Sanofi inks five-year pact to license Owkin’s AI Scientist K Pro for next-generation biopharma agents
Sanofi has entered into a definitive multi-year licensing agreement with Owkin, an agentic AI company pioneering biological artificial superintelligence for... Read more
J&J wins lawsuit alleging talc-based baby powder caused ovarian cancer in three women
A Los Angeles jury has ruled in favor of Johnson & Johnson (J&J) in a product liability lawsuit initiated by... Read more
Incyte nears up to $2 billion acquisition of blood disorder biotech Star Therapeutics, FT reports
U.S. biotechnology company Incyte Pharma is nearing a definitive agreement valued at up to $2 billion to acquire Star Therapeutics,... Read more
Eli Lilly states next-gen obesity drug retatrutide curbs sleep apnea and eases knee pain
Drugmaker Eli Lilly has presented milestone clinical trial results to medical professionals, demonstrating that its next-generation obesity drug, retatrutide, significantly... Read more
Pfizer’s monthly obesity shot demonstrates side-effect profile comparable to Wegovy in midstage trial
Pharmaceutical giant Pfizer has presented novel clinical trial data demonstrating that a monthly dose of its experimental obesity drug exhibits... Read more









